Aquarius Surgical Technologies Inc.
AQQRF
$0.00
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 73.40% | -50.55% | -29.05% | -56.98% | -77.18% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 73.40% | -50.55% | -29.05% | -56.98% | -77.18% |
| Cost of Revenue | 71.43% | -49.23% | -38.95% | -63.25% | -74.35% |
| Gross Profit | 75.56% | -51.72% | -17.86% | -51.77% | -79.64% |
| SG&A Expenses | -73.86% | -32.75% | -39.94% | -46.46% | 45.25% |
| Depreciation & Amortization | -69.23% | -9.26% | -15.79% | -17.54% | -8.77% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -68.74% | -33.44% | -38.74% | -46.71% | 22.79% |
| Operating Income | 78.76% | 28.69% | 40.40% | 44.20% | -78.30% |
| Income Before Tax | -141.31% | -260.46% | 417.85% | -112.57% | -27.98% |
| Income Tax Expenses | -- | -- | -- | -78.85% | -- |
| Earnings from Continuing Operations | -141.31% | -263.24% | 417.85% | -106.45% | -27.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -141.31% | -263.24% | 417.85% | -106.45% | -27.98% |
| EBIT | 78.76% | 28.69% | 40.40% | 44.20% | -78.30% |
| EBITDA | 79.15% | 29.81% | 40.33% | 44.15% | -85.55% |
| EPS Basic | -141.27% | -261.02% | 415.25% | -106.78% | -28.57% |
| Normalized Basic EPS | 46.51% | 8.33% | 16.22% | 32.43% | -43.33% |
| EPS Diluted | -141.27% | -261.02% | 415.25% | -106.78% | -28.57% |
| Normalized Diluted EPS | 46.51% | 8.33% | 16.22% | 32.43% | -43.33% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |